Opinion|Videos|May 15, 2024
Optimizing Complex Pulmonary Arterial Hypertension Care: Enhancing Adherence and Outcomes
Author(s)Ioana Preston, MD
Focusing on the complexity of PAH management, Ioana Preston, MD, discusses the importance of combination therapies, close monitoring, and provides insight on counseling patients through treatment.
Advertisement
Episodes in this series
Video content above is prompted by the following question:
- How does the complexity of pulmonary arterial hypertension (PAH) management, including the need for combination therapies and close monitoring, impact patient adherence and disease control?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Vutrisiran Improves Survival, Cardiovascular Outcomes Across Age Groups in ATTR-CM
2
Contributor: The Majority (57.5%) of Commercially Insured Patients Had 1 or More Chronic Conditions in 2024
3
Prior Authorization Ranked Top Barrier to Health Care Access After Cost
4
Most Patients With MCL in Study of Pirtobrutinib Show Stable or Improved Physical Symptoms, QOL
5
